|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
[Insulin-Sensitizing Agents as Primary Therapy for Patients with Polycystic Ovarian Syndrome] |
|||
|
Kashyap S, Wells GA, Rosenwaks Z |
|||
|
Los autores no manifiestan conflictos de interés |
|||
|
Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canadá; Centre for Reproductive Medicine, Weill Sanford Medical College of Cornell University |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|